摘要
目的探讨miR-203在肺腺癌中的表达,并分析其与肺腺癌细胞侵袭转移的关系及其分子机制。方法实时定量PCR检测40例肺腺癌患者肿瘤组织中miR-203的相对表达水平及其与临床病理特征之间的关系;实时定量PCR检测H1650、A549、H1975、SPC-A-1肺腺癌细胞株中miR-203表达水平;生物信息学软件预测miR-203潜在的靶基因;脂质体2000介导miR-203模拟物、Bmi-1基因或Bmi-1 siRNA转染H1975细胞株;Western blotting检测Bmi-1蛋白水平;双荧光素酶报告基因验证miR-203是否作用于Bmi-1 mRNA的3’UTR区预测靶位;Transwell小室侵袭实验检测H1975细胞株的侵袭转移能力。结果 40例肺腺癌组织中miR-203的相对表达量为0.065±0.013;肺腺癌miR-203表达与淋巴结转移有关,而与其他临床病理参数均无关;miR-203在肺腺癌细胞株H1650、A549、H1975、SPC-A-1中的相对表达量分别为0.280±0.102、0.308±0.168、0.167±0.073和0.287±0.096。生物信息学软件预测Bmi-1是miR-203的潜在靶基因;过表达miR-203可明显降低Bmi-1蛋白表达水平;双荧光素酶报告基因检测证明miR-203可作用于Bmi-1基因mRNA的3’UTR区预测靶位。过表达miR-203+Bmi-1 siRNA可显著抑制肺腺癌细胞株H1975的侵袭迁移能力;在miR-203过表达的H1975细胞株中同时过表达Bmi-1可恢复其侵袭能力。结论 miR-203可通过下调Bmi-1基因表达抑制H1975肺腺癌细胞株的侵袭转移,是一种潜在抑制转移的miRNA分子。
Objective To investigate the expression of miR-203 in lung adenocarcinoma and analyze the relationship between miR-203 and migration and invasion of lung adenocarcinoma cells. The involved molecular mechanisms are also initially explored. Methods miR-203 was detected in lung tissues of 40 patients with lung adenocarcinoma by real time PCR. The expression of miR-203 was detected in lung adenocarcinoma cell lines H1650, A549, H1975, SPC-A-1 by real time PCR. The potential target gene of miR-203 was predicted by online bioinformatic softwares. Pre-miR-203 mimics, Bmi-1 gene and Bmi-1 siRNA were transfected into H1975 cell line by lipofectamine 2000. The Bmi-1 protein level was analyzed by Western blotting. The predicted miR-203 binding site in Bmi-1 3’-untranslated region( UTR) was validated by dual-luciferase reporter gene assay. The migration ability of H1975 cells was determined by Transwell assay. Results The relative expression of miR-203 in lung adenocarcinoma tissues was 0?065 ± 0?013. The expression level of miR-203 in the lymph node metastasis group was lower than those in the non-metastasis group. The relative expression of miR-203 in H1650, A549, H1975 and SPC-A-1 cell lines were 0?280 ± 0?102, 0?308 ± 0?168, 0?167 ± 0?073 and 0?287 ± 0?096, respectively. Bmi-1 was a potential target gene of miR-203 predicted by miRanda and TargetScan. The Bmi-1 protein level was remark-ably decreased in the pre-miR-203 mimics group. Dual-luciferase reporter gene assay validated the predicted miR-203 binding site of Bmi-1 3’ UTR. Overexpression of miR-203 significantly inhibited the migration and invasion of H1975 cells, whereas the cell migration and invasion ability could be restored by overexpression of Bmi-1. Conclusion miR-203 can suppress the migration of lung adenocar-cinoma cell line H1975 via down-regulating Bmi-1 expression. miR-203 might be a potential tumor metastasis suppressor miRNA.
出处
《临床肿瘤学杂志》
CAS
2014年第4期289-293,共5页
Chinese Clinical Oncology
基金
江苏省自然科学基金资助项目(BK2010589
BK2011857)
江苏省"六大人才高峰"第七批高层次人才项目(10-D-078)
国家自然科学基金资助项目(81201830
81372321)
2012年卫生部(江苏省)科研项目课题资助(W6)
江苏省科技厅临床科技专项基金资助项目(BL2012030)